Literature DB >> 3317748

Chemical structure and biologic activity of bacterial and synthetic lipid A.

E T Rietschel1, L Brade, K Brandenburg, H D Flad, J de Jong-Leuveninck, K Kawahara, B Lindner, H Loppnow, T Lüderitz, U Schade.   

Abstract

The chemical structure of the lipid A component of enterobacterial lipopolysaccharide (LPS) is now known in some detail. For example, lipid A of Escherichia coli consists of a beta(1----6)-linked D-glucosamine disaccharide that carries four (R)-3-hydroxytetradecanoyl groups in positions 2, 3, 2', and 3' and two phosphoryl residues in positions 1 and 4'. The hydroxy fatty acids at positions 2' and 3' are acylated at their 3-hydroxyl groups by dodecanoic acid and tetradecanoic acid, respectively. The hydroxyl groups in positions 4 and 6' are free, the latter serving as the attachment site for the polysaccharide component in intact LPS. On the basis of this structure, E. coli-type lipid A and partial structures thereof have been chemically synthesized (group of T. Shiba, Osaka University, Osaka, Japan) and analyzed for endotoxic activity. In all in vivo and in vitro test systems employed (including lethal toxicity, pyrogenicity, local Shwartzman reactivity, B lymphocyte mitogenicity, macrophage activation, and serologic cross-reactivity with lipid A antiserum), synthetic lipid A has activity identical to that of E. coli lipid A. These findings support the structural proposal for lipid A and prove the previous hypothesis that the endotoxic principle is embedded in lipid A.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3317748     DOI: 10.1093/clinids/9.supplement_5.s527

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  16 in total

Review 1.  The biology of endotoxin.

Authors:  H Heine; E T Rietschel; A J Ulmer
Journal:  Mol Biotechnol       Date:  2001-11       Impact factor: 2.695

2.  Identification and characterization of lipopolysaccharide-binding proteins on human peripheral blood cell populations.

Authors:  J L Halling; D R Hamill; M G Lei; D C Morrison
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

3.  Serum-independent binding of lipopolysaccharide to human monocytes is trypsin sensitive and does not involve CD14.

Authors:  I Corrales; A J Weersink; J Verhoef; K P van Kessel
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

4.  P. gingivalis and E. coli lipopolysaccharides exhibit different systemic but similar local induction of inflammatory markers.

Authors:  Rongkun Liu; Tesfahun Desta; Markos Raptis; Richard P Darveau; Dana T Graves
Journal:  J Periodontol       Date:  2008-07       Impact factor: 6.993

5.  Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides.

Authors:  A P Moran; I M Helander; T U Kosunen
Journal:  J Bacteriol       Date:  1992-02       Impact factor: 3.490

6.  Augmented immunological activities of recombinant lipopolysaccharide possessing the mannose homopolymer as the O-specific polysaccharide.

Authors:  N Paeng; N Kido; G Schmidt; T Sugiyama; Y Kato; N Koide; T Yokochi
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

7.  Chemical differences in lipopolysaccharides from Actinobacillus (Haemophilus) actinomycetemcomitans and Haemophilus aphrophilus: clues to differences in periodontopathogenic potential and taxonomic distinction.

Authors:  I Brondz; I Olsen
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

8.  Endotoxic lipid A induces intracellular Ca2+ increase in human platelets.

Authors:  M Romano; M Molino; C Cerletti
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

9.  Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature.

Authors:  Kazuyoshi Kawahara; Hiroko Tsukano; Haruo Watanabe; Buko Lindner; Motohiro Matsuura
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 10.  Immunopharmacology of lipid A mimetics.

Authors:  William S Bowen; Siva K Gandhapudi; Joseph P Kolb; Thomas C Mitchell
Journal:  Adv Pharmacol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.